Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Tribune Content Agency on MSN
Medicare to cover obesity drugs under Trump deal for as little as $50
The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...
Novo Nordisk is rated a 'Strong Buy' due to its undervaluation, wide economic moat, and long-term growth prospects despite ...
Opinion
Zacks Investment Research on MSNOpinion
Top Research Reports for Microsoft, Amazon.com & Eli Lilly
Tuesday, November 18, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft ...
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...
Novo Nordisk goes "on the offensive" following Trump deal that also included rival Eli Lilly, putting an exclamation point on rapidly declining GLP-1 drug prices. Experts say the unusual situation ...
16hon MSN
Can AI Drive Peloton's Comeback?
Detailed price information for Coinbase Global Inc Cl A (COIN-Q) from The Globe and Mail including charting and trades.
United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of ...
Eli Lilly and Company has announced two significant strategic developments that could reshape its long-term growth trajectory ...
Sen. Ruben Gallego (D-Ariz.) is asking for more information on Eli Lilly’s recently announced agreement with the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results